Shill Manik C, Huda Naz H, Moain Fahad B, Karmakar Utpal K
Oman Med J. 2010 Oct;25(4):282-5. doi: 10.5001/omj.2010.82.
Urinary tract infection is the second most common clinical indication for empirical antibiotic treatment in primary and secondary health care settings. The incidence of diabetes mellitus throughout the world is increasing strikingly and in the long run, it has some major effects on the genitourinary system which makes diabetic patients more liable to urinary tract infection. This study is designed to reveal the distribution of uropathogens in diabetic patients according to age and sex, and corresponding resistance patterns.
A six-month retrospective review of urine culture assay data from August 2009 to January 2010 from randomly selected 85 patients who suffered from both urinary tract infection and diabetes was conducted. Relevant information was retrieved and analyzed statistically using Microsoft® Excel 2002 software.
The study showed that females are more vulnerable to pathogenic attack than males throughout a wide age distribution. In terms of pathogenic distribution, Escherichia coli was the highest followed by Streptococcus sp., Acinetobacter, Klebsiella pneumoniae and few others. Though Meropenem showed no resistance with E. coli, Acinetobacter and Klebsiella pneumoniae, in the case of Streptococcus sp. it exhibited resistance of 25%. Amikacin exhibited only 3% resistance with E. coli, whereas no resistance with Acinetobacter and Klebsiella pneumoniae, and most interestingly showed 75% resistance with Streptococcus sp. Gentamicin exhibited no resistance with Acinetobacter while 26.9%, 50% and 87.5% resistance with E. coli, Klebsiella pneumoniae and Streptococcus sp. respectively. Hence, Nitrofurantoin exhibited less resistance 11.9% compared to 12.5% resistance with E. coli and Streptococcus sp. Nitrofurantoin was highly prone to resistance with Acinetobacter and Klebsiella pneumoniae (100%, 50% respectively). Cephalosporins (cephradine, cefixime, ceftriaxone, cefepime etc.) showed moderate resistance (avg. 50%), whereas amoxicillin and ciprofloxacin showed the highest resistance in all these cases.
Pathogens are mostly resistant to antibiotics including amoxicillin, ciprofloxacin, cephalosporins and nitrofurantoin, with few exceptions including gentamicin, amikacin and meropenem.
尿路感染是基层和二级医疗保健机构中经验性抗生素治疗的第二大常见临床指征。全球糖尿病发病率正在显著上升,从长远来看,它对泌尿生殖系统有一些重大影响,这使得糖尿病患者更容易发生尿路感染。本研究旨在揭示糖尿病患者中尿路病原体按年龄和性别的分布情况以及相应的耐药模式。
对2009年8月至2010年1月随机选取的85例同时患有尿路感染和糖尿病的患者的尿培养检测数据进行为期6个月的回顾性分析。使用Microsoft® Excel 2002软件检索相关信息并进行统计分析。
研究表明,在广泛的年龄分布范围内,女性比男性更容易受到病原体攻击。在病原体分布方面,大肠杆菌最为常见,其次是链球菌属、不动杆菌、肺炎克雷伯菌等。虽然美罗培南对大肠杆菌、不动杆菌和肺炎克雷伯菌没有耐药性,但对链球菌属的耐药率为25%。阿米卡星对大肠杆菌的耐药率仅为3%,对不动杆菌和肺炎克雷伯菌没有耐药性,最有趣的是对链球菌属的耐药率为75%。庆大霉素对不动杆菌没有耐药性,而对大肠杆菌、肺炎克雷伯菌和链球菌属的耐药率分别为26.9%、50%和87.5%。因此,呋喃妥因的耐药率为11.9%,低于对大肠杆菌和链球菌属12.5%的耐药率。呋喃妥因对不动杆菌和肺炎克雷伯菌极易产生耐药性(分别为100%、50%)。头孢菌素(头孢拉定、头孢克肟、头孢曲松、头孢吡肟等)显示出中等耐药性(平均50%),而阿莫西林和环丙沙星在所有这些病例中显示出最高耐药性。
病原体大多对包括阿莫西林、环丙沙星、头孢菌素和呋喃妥因在内的抗生素耐药,少数例外包括庆大霉素、阿米卡星和美罗培南。